wla(warner lambert) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : wla(warner lambert)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: John F Beule who wrote (894)	11/5/1999 3:55:00 AM
From: billkirn	Read Replies (1) of 942

John: No matter what happens, the old Agouron group who kept WLA stock are doing pretty darn well. My sense is that WLA and AHP will make a better combination. Long term cost savings will be considerable and AHP's product pipeline combined with additional sales and distribution force of WLA is a great match. PFE-WLA is a good short term shot for WLA stock holders, but very much less attractive over the long term. Look out 5 years and wonder where PFE-WLA will get new drug candidates. Pretty scary here. If PFE does win the battle, sell WLA immediately. If AHP and WLA make it through this new hurdle, hold for a good 20% per year appreciation over the long term. I like the long term approach. William H. Kirn

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next